Stoke Therapeutics, Inc. STOK
Nasdaq · XNAS · stock · Pharmaceutical Preparations · website · IPO 2019-06-19
Stoke Therapeutics, Inc. institutional holders (13F)
| Investor | Shares | Value |
|---|---|---|
| BlackRock Finance, Inc. | 5,409,169 | $73.1M |
| MILLENNIUM MANAGEMENT LLC | 512,141 | $16.7M |
| CITADEL ADVISORS LLC | 179,422 | $5.8M |
| D. E. Shaw & Co., Inc. | 49,972 | $1.6M |
| AQR CAPITAL MANAGEMENT LLC | 46,459 | $1.5M |
Source: SEC EDGAR filings · CIK 0001623526 · as of 2025-12-31. Facts from filings plus Stocktoria's own computed scores — not investment advice.